Moffitt logo

Clinical Trials Search

Clinical Trial 22117

Cancer Type: Gastrointestinal Tumor
Study Type: Supportive Care
NCT#: NCT05649969

Phase: N/A
Principal Investigator: Turner, Kea

Call 813-745-6100
or 1-800-679-0775 Learn More

Study Title

STRONG-PD: Support Through Remote Observation And Nutrition Guidance (STRONG) Program For Cancer Patients With Peritoneal Disease


The purpose of the study is to assess the feasibility and participant satisfaction with the Support through Remote Observation and Nutrition Guidance (STRONG) program. The program provides nutrition support for participants living with gastrointestinal cancer who are receiving chemotherapy and surgical treatment.


Aim 1: Assess the feasibility, acceptability, and usability of remote malnutrition monitoring among cancer patients with peritoneal disease initiating CRS-HIPEC. Aim 2: Collect pilot data on malnutrition (weight, BMI, muscle mass), malnutrition-related symptom burden, quality of life and treatment outcomes among cancer patients with peritoneal disease initiating CRS-HIPEC




Inclusion Criteria

Inclusion Criteria:

  • 18 years of age or older
  • Gastrointestinal Cancer diagnosis (e.g., colon cancer, appendiceal cancer)
  • Peritoneal disease diagnosis
  • Received Cytoreductive Surgery and Heated Intra-Peritoneal Chemotherapy (CRS-HIPEC) for curative intent at Moffitt
  • Transitioned to an oral diet post-surgery
  • Able to speak and read English
  • Able to provide informed consent

  • Exclusion Criteria

    Exclusion Criteria:

  • Documented or observable psychiatric or neurological disorder that would interfere with study participation (e.g., psychosis, active substance abuse)
  • Undergoing concurrent treatment for a secondary primary cancer
  • Receipt of parenteral or enteral nutrition after surgery

  • If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.